Research On The Development Strategy Of Y Biological Pharmaceutical Co., Ltd

The economy and GDP have been growing stably in China,and individuals have a higher level of both material and spiritual civilization.In order to improve people's living quality,China has put health as one of the national strategies.Meanwhile,the development of bioscience and biotechnology accelerated the rise of biopharmaceutical industry,which provides a new way to guarantee human health care.And the increasing population,aging problem and a higher consumption level are providing a much wider marketing for biopharmaceutical companies.In China,the domestic biopharmaceutical industry started late but is developing rapidly,involved in hundreds of companies with various abilities.In the world,by contrast,under the process of globalization,those giant pharmaceutical enterprises with its advantages of abundant capital and R&D strength have shared most of the marketing worldwide.Furthermore,they have launched their business very early in China and are much more competitive than domestic companies.Therefore,China has carried out dozens of policies and plans to improve the pharmaceutical industry system and to support and lead companies to a higher quality.These measures are to reform the medical system and amend the producing and circulating of pharmacy products in accordance with international standards,to implement new tax system for a better supervision of companies and marketing,and to encourage pharmaceutical companies to pass the evaluation of generic pharmacy products,which will enhance the competitiveness of domestic pharmaceutical companies,reduce medical costs and protect people's health and interests.This paper is based on the analysis of Y Biopharmaceutical Limited Liability Company and its external political,economic,social,technological and industrial environment,as well as its internal strengths,weaknesses,opportunities and threats by SWOT method,and provides suggestions for its strategy,organization,human resource,financial management,production management,quality and technology management from the point of strategy management to meet the long-term profit and sustainable development.It is also a reference to other middle and small sized pharmaceutical companies.